Neoleukin Therapeutics (NASDAQ:NLTX) Director Bros. Advisors Lp Baker acquired 371,525 shares of the firm’s stock in a transaction on Wednesday, August 7th. The shares were acquired at an average price of $3.00 per share, with a total value of $1,114,575.00.
Neoleukin Therapeutics stock opened at $3.23 on Thursday. Neoleukin Therapeutics has a 52-week low of $2.00 and a 52-week high of $4.23.
About Neoleukin Therapeutics
Featured Story: Trading signals using Bollinger bands
Receive News & Ratings for Neoleukin Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neoleukin Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.